Health economics in HIV disease

被引:0
|
作者
Youle, M [1 ]
机构
[1] Royal Free Hosp, Royal Free Ctr HIV Med, London NW3 2QG, England
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
All illnesses and, by association, all provision of health care in any setting have a cost, whether it is the direct cost to the consumer, to the provider (for example, a national health service) or the indirect cost to an employer or to society in lost production. Disease also has hidden or intangible costs of pain, suffering, and distress for the people affected and for their surrounding support structure such as family and friends. The ability to provide what is currently perceived as the treatment standard of care, in human immunodeficiency virus (HIV) disease, is stretching many health care budgets globally, yet few studies of health economics have been conducted in this area. Such studies are needed and increasingly will become a vital resource regarding health cave costs and utilization for optimal provision of health care in HIV disease.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 50 条
  • [1] Health economics in HIV disease - A review of the European literature
    Youle, M
    Trueman, P
    Simpson, K
    [J]. PHARMACOECONOMICS, 1999, 15 (Suppl 1) : 1 - 12
  • [2] ECONOMICS OF HEALTH AND DISEASE
    不详
    [J]. WHO CHRONICLE, 1971, 25 (01) : 20 - &
  • [3] Wealth, health, HIV and the economics of hope
    Barnett, Tony
    Weston, Mark
    [J]. AIDS, 2008, 22 : S27 - S34
  • [4] Health Economics in HIV DiseaseA Review of the European Literature
    Mike Youle
    P. Trueman
    K. Simpson
    [J]. PharmacoEconomics, 1999, 15 : 1 - 12
  • [5] ECONOMICS, HEALTH, AND THE ECONOMICS OF HEALTH
    NORMAND, C
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6817): : 1572 - 1577
  • [6] The economics of health and the health of economics
    Reekie, WD
    [J]. SOUTH AFRICAN JOURNAL OF ECONOMICS, 1997, 65 (03) : 283 - 313
  • [7] The costs of musculoskeletal disease: health needs assessment and health economics
    Lubeck, DP
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (03): : 529 - 539
  • [8] HEALTH ECONOMICS AND HEALTH POLICY ISSUES IN ALZHEIMER'S DISEASE
    Rapp, T.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2010, 14 (08): : 630 - 632
  • [9] A Systematic Review of the Health Economics of Pompe Disease
    Benedikt Schoser
    Andreas Hahn
    Emma James
    Digant Gupta
    Matthew Gitlin
    Suyash Prasad
    [J]. PharmacoEconomics - Open, 2019, 3 : 479 - 493
  • [10] One Health Economics to confront disease threats
    Machalaba, Catherine
    Smith, Kristine M.
    Awada, Lina
    Berry, Kevin
    Berthe, Franck
    Bouley, Timothy A.
    Bruce, Mieghan
    Abrahantes, Jose Cortinas
    El Turabi, Anas
    Feferholtz, Yasha
    Flynn, Louise
    Fournie, Giullaume
    Andre, Amanda
    Grace, Delia
    Jonas, Olga
    Kimani, Tabitha
    Le Gall, Francois
    Miranda, Juan Jose
    Peyre, Marisa
    Pinto, Julio
    Ross, Noam
    Ruegg, Simon R.
    Salerno, Robert H.
    Seifman, Richard
    Zambrana-Torrelio, Carlos
    Karesh, William B.
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2017, 111 (06) : 235 - 237